Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
AMGN's Subcutaneous Tepezza Scores Phase III Win in Thyroid Eye Disease
10:56am, Tuesday, 07'th Apr 2026
Amgen's subcutaneous Tepezza hits phase III goals in thyroid eye disease, matches IV efficacy and offers faster dosing that could expand access.
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
10:01am, Tuesday, 07'th Apr 2026
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.
12:10pm, Monday, 06'th Apr 2026
Amgen announces encouraging results in a Phase 3 trial for a new treatment of thyroid eye disease. Viridian Therapeutics is currently developing its own treatment for the disease.
Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful Reduction in Proptosis; Greater Than 3 mm THOUSA
Savvy Advisors Inc. Boosts Holdings in Amgen Inc. $AMGN
05:43am, Monday, 06'th Apr 2026
Savvy Advisors Inc. grew its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 20.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission
Buffalo Business & Estate Services Ltd. Takes Position in Amgen Inc. $AMGN
05:06am, Monday, 06'th Apr 2026
Buffalo Business and Estate Services Ltd. acquired a new position in Amgen Inc. (NASDAQ: AMGN) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm
Amgen Inc. $AMGN Shares Sold by Access Financial Services Inc.
03:05am, Monday, 06'th Apr 2026
Access Financial Services Inc. reduced its holdings in Amgen Inc. (NASDAQ: AMGN) by 46.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,0
Dorato Capital Management Invests $1.58 Million in Amgen Inc. $AMGN
05:20am, Friday, 03'rd Apr 2026
Dorato Capital Management purchased a new position in Amgen Inc. (NASDAQ: AMGN) in the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 4,799
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors
06:50pm, Thursday, 02'nd Apr 2026
Amgen (AMGN) closed at $347.94 in the latest trading session, marking a -1.51% move from the prior day.
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory
05:32pm, Thursday, 02'nd Apr 2026
Healthcare is a defensive sector worth looking into when the going gets rough. These two pharmaceutical leaders have strong businesses and attractive dividend programs.
Global pharma companies that have publicly announced Trump drug pricing agreements
02:59pm, Thursday, 02'nd Apr 2026
U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in exchange for three-ye
Amgen Inc. $AMGN is Ellsworth Advisors LLC’s 8th Largest Position
04:43am, Thursday, 02'nd Apr 2026
Ellsworth Advisors LLC lifted its holdings in Amgen Inc. (NASDAQ: AMGN) by 7.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced a global clinical trial collaboration with Amgen Inc. (NASDAQ: AMGN) to evaluate Zai Lab's inve
Econ Financial Services Corp Buys 1,660 Shares of Amgen Inc. $AMGN
04:18am, Wednesday, 01'st Apr 2026
Econ Financial Services Corp increased its stake in Amgen Inc. (NASDAQ: AMGN) by 24.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. Th
April Dogs Of The Dow: One To Buy
12:04pm, Tuesday, 31'st Mar 2026
Verizon (VZ) is the only Dow stock in April 2026 meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by robust free cash flow. Analyst forecasts suggest the to
